Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma Seeking Democratic Allies In Senate: Nelson, Bayh May Be Contacts

Executive Summary

The retirement of Sen. John Breaux (D-La.) means that the brand name pharmaceutical industry is losing one of its best allies in the Senate minority heading into the Medicare Rx implementation process

You may also be interested in...



HHS Price Negotiators: Wyden, Thompson And “Non-Interference”

Incoming Senate Finance Committee member Ron Wyden (D-Ore.) is likely to play a central role in the push for legislation to give HHS greater leverage over drug pricing under Medicare

HHS Price Negotiators: Wyden, Thompson And “Non-Interference”

Incoming Senate Finance Committee member Ron Wyden (D-Ore.) is likely to play a central role in the push for legislation to give HHS greater leverage over drug pricing under Medicare

Medicare Rx Course Is Clearer Following Bush Victory

President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare

Topics

UsernamePublicRestriction

Register

PS045036

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel